WARPTECHNEWS · LAB

Home AI Business Tech Archive

FDA approves smallest single-pill HIV regimen, Bixlenvo

The FDA has approved Bixlenvo, the first single-pill daily HIV therapy for adults being successfully treated on more complex regimens who are unable to take other available single-tablet HIV medications. The accelerated approval was announced by Gilead Sciences, which developed the single-tablet regimen combining two of its existing drugs:

venerdì 28 agosto 2026 New tab

471 words~2 min read

August 28, 2026

1 min read

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

Home
Archivio
Editor's Brief
Cerca
Il tuo account
Newsletter tech/AI

Informazioni legali

Privacy Policy
Termini di servizio
Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Other newsrooms on this story

· 9 sources

Full timeline →

qz.com·Aug 28, 2026 · 2 g fa
FDA approves Gilead's Bixlenvo HIV pill for complex regimens
cnbc.com·Aug 27, 2026 · 3 g fa
FDA approves daily HIV pill from Gilead designed to simplify treatment for some patients
morningstar.com·Aug 28, 2026 · 3 g fa
U.S. FDA Approves Gilead’s Bixlenvo™, a New Once-Daily Single Tablet Option for Virologically Suppressed Adults With HIV, Including Those on Complex Regimens
newsbytesapp.com·Aug 28, 2026 · 2 g fa
FDA approves new once-daily pill to simplify HIV treatment
medpagetoday.com·Aug 28, 2026 · 2 g fa
Bictegravir-Lenacapavir Combo Pill Earns FDA Approval in Suppressed HIV
fiercepharma.com·Aug 27, 2026 · 3 g fa
Gilead christens Bixlenvo with FDA nod for new HIV treatment combo tablet
endpoints.news·Aug 28, 2026 · 3 g fa
Gilead gets another HIV treatment approval, extending lenacapavir's dominance
morningstar.com·Aug 26, 2026 · 4 g fa
U.S. FDA approves ViiV Healthcare’s Tivicay PD, helping close a critical HIV treatment gap for young children
medpagetoday.com·Aug 26, 2026 · 4 g fa
FDA Expands Label of Oral HIV Drug to Newborns

Related reading

FDA approves Gilead's Bixlenvo HIV pill for complex regimens

Bixlenvo combines two existing Gilead drugs into a single tablet for adults whose virus is suppressed but who can't use current…

qz.com·2 g fa

FDA approves daily HIV pill from Gilead designed to simplify treatment for some…

The new pill is also aimed at people who are doing well on a single-tablet regimen, including Biktarvy, and want to switch to a…

cnbc.com·3 g fa

morningstar.com

U.S. FDA Approves Gilead’s Bixlenvo™, a New Once-Daily Single Tablet Option for…

U.S. FDA Approves Gilead’s Bixlenvo™, a New Once-Daily Single Tablet Option for Virologically Suppressed Adults With HIV,…

morningstar.com·3 g fa

newsbytesapp.com

FDA approves new once-daily pill to simplify HIV treatment

The FDA has approved Gilead's once-daily HIV pill, Bixlenvo, designed to simplify treatment for patients with controlled virus…

newsbytesapp.com·2 g fa

medpagetoday.com

Bictegravir-Lenacapavir Combo Pill Earns FDA Approval in Suppressed HIV

Combo could offer an alternative for those who can't take existing single-tablet regimens

medpagetoday.com·2 g fa

fiercepharma.com

Gilead christens Bixlenvo with FDA nod for new HIV treatment combo tablet

Some 20 years after helping introduce the first once-daily single tablet HIV regimen, Gilead Sciences has crossed the regulatory…

fiercepharma.com·3 g fa

FDA approves smallest single-pill HIV regimen, Bixlenvo — Warptech Lab News